Lupus erythematosus and the skin

Clinical and Experimental Rheumatology

Volumn 24, Issue SUPPL. 40, 2006, Pages

  Bano, S ^a   Bombardieri, S ^b   Doria, A ^a   Iaccarino, L ^a   Lehmann, P ^c   Mosca, M ^b   Rondinone, R ^a   Sontheimer, R D ^d   Kuhn, Annegret ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anti Ro SS A antibodies; Differential diagnosis; Lupus erythematosus; Photosensitivity; Skin manifestations; Subacute cutaneous lupus erythematosus

Indexed keywords

AUTOANTIBODY; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; RO ANTIBODY;

ANTIBODY PRODUCTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION;

HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOTOSENSITIVITY DISORDERS; SKIN;

EID: 33645024653     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. GILLIAM JN: The cutaneous signs of lupus erythematosus. Cont Educ Fam Phys 1977; 6: 34-70.
2. SONTHEIMER RD: The lexicon of cutaneous lupus erythematosus - a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997; 6: 84-95.
3. KUHN A, RICHTER-HINTZ D, OSLISLO C, RUZICKA T, MEGAHED M, LEHMA NN P: Lupus erythematosus tumidus - a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 2000; 136: 1033-41.
4. KUHN A, RUZICKA T: Classification of cutaneous lupus eyrthematosus. In: KUHN A, LEHMANN P and RUZICKA T (Eds.): Cutaneous Lupus Erythematosus. Springer, Heidelberg 2004; 53-8.
5. COSTNER MI, SONTHEIMER RD, PROVOST TT: Lupus erythematosus. In: SONTHEIMER RD and PROVOST TT (Eds.): Cutaneous Manifestations of Rheumatic Diseases. Williams & Wilkins, Philadelphia, 2003; 15-64.
6. KUHN A, SONTHEIMER RD, RUZICKA T: Clinical manifestations of cutaneous lupus erythematosus. In: KUHN A, LEHMANN P, RUZICKA T (Eds.): Cutaneous Lupus Erythematosus. Springer, Heidelberg, 2004; pp. 59-92.
7. YELL JA, MBUAGBAW J, BURGE SM: Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996; 135: 355-62.
8. SONTHEIMER RD: Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005; 4: 253-63.
9. UEKI H: Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmunity 2005; 4: 219-23.
10. PACHECO TR, SPATES ST, LEE LA: Unilateral tumid lupus erythematosus. Lupus 2002; 11: 388-91.
11. CHLEBUS E, WOLSKA H, BLASZCZYK M, JABLONSKA S: Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus. Diagnostic criteria and therpeutic options. J Am Acad Dermatol 1998; 38: 405-12.
12. DAVID-BAJAR KM, BENNION SD, DESPAIN JD, GOLITZ LE, LEE LA: The clinical, histologic and immunofluorescent distinctions betwen subactue cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 1992; 99: 251-7.
13. DUTZ JP, SONTHEIMER RD: The pathogenesis of LE-specific skin disease. In: Dubois' Lupus Erythematosus. 6th ed., Philadelphia, Lippincott-Williams & Wilkins, 2002: 549-71.
14. FAUTREL B, FOLTZ V, FRANCES C, BOURGEOIS P, ROZENBERG S: Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: Comment on the article by Pisetsky and the letter from Aringer et al. Arthritis Rheum 2002 ; 46: 1408-9.
15. KUHN A, SONNTAG M, RICHTER-HINTZ D et al.: Phototesting in lupus erythematosus: A 15-year experience. J Am Acad Dermatol 2001; 45: 86-95.
16. SONTHEIMER RD: Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol 2004; 18: 29-462.
17. SONTHEIMER RD: The management of dermatomyositis: current treatment options. Expert Opin Pharmacother 2004; 5: 1083-99.
18. FURUKAWA F: Photosensitivity in cutaneous lupus erythematosus: lessons from mice and men. J Dermatol Sci 2003; 33: 81-9.
19. JANSSENS AS, LASHLEY EE, OUT-LUITING CJ, WILLEMZE R, PAVEL S, de GRUIJL FR: UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells. Exp Dermatol 2005; 14: 138-42
20. KIND P, LEHMANN P, PLEWIG G: Phototesting in lupus erythematosus. J Invest Dermatol 1993; 100: 53-7.
21. KUHN A, SONNTAG M, RUZICKA T, LEHMANN P, MEGAHED M: Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol 2003; 48: 901-8.
22. KUHN A, SONNTAG M, RICHTER-HINTZ D et al.: Phototesting in lupus erythematosus tumidus - review of 60 patients. Photochem Photobiol 2001; 73: 532-6.
23. KUHN A, SCHUPPE HC, RUZICKA T, LEHMANN P: Rare cutaneous manifestations of lupus erytheamtosus. A clinical overview. Hautarzt 2000; 51: 818-25.
24. LEHMANN P, HÖLZLE E, KIND P, GOERZ G, PLEWIG G: Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990; 22: 181-7.
25. MELLER S, WINTERBERG F, GILLIET M et al.: Ultraviolet radiation-induced injury, chemokines and leuckocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52: 1504-616.
26. BIGBY M: Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-70.
27. STRATIGOS AJ, ANTONIOU C, KATSAMBAS AD: Polymorphous light eruption. J Eur Acad Dermatol Venereol 2002; 16: 193-206.
28. TUTRONE WD, SPANN CT, SCHEINFELD N et al.: Polymorphic light eruption. Dermatol Ther 2003; 16: 28-39.
29. JESSNER M, KANOF NB: Lymphocytic infiltration of the skin. Arch Dermatol 1953; 68: 447-9.
30. ZIRWAS MJ, ABELL E, RUBEN A et al.: Immunofluorescence findings in granuloma faciale: report of two cases. J Cutan Pathol 2003; 30: 314-7.
31. CRIBIER B, DJERIDI N, PELTRE B et al.: A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 2001; 45: 924-9.
32. CROWSON AN, MAGRO CM: Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases. Hum Pathol 1997; 28: 478-84.
33. ALTERAS I, SANDBANK M, DAVID M et al.: 15-year survey of tinea faciei in the adult. Dermatologica 1988; 177, 65-9.
34. ANNESSI G, LOMBARDO G, GOBELLO T et al.: A clinicopathologic study of scarring alopecia due to lichen planus: a comparison with scarring alopecia in discoid lupus erythematosus and pseudopelade. Am J Dermatopathol 1999; 21: 324-31.
35. STRAND V, GLADMAN D, ISENBERG D, PETRI M, SMOLEN J, TUGWELL P: Endpoints: consensus recommendations from OMERACT IV Lupus 2000; 9: 322-7.
36. WARD MM, MARX AS, BARRY NN: Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000; 27: 664-70.
37. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria: The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 2004; 50: 3418-26.
38. CERVERA R, KHAMASHTA MA, FONT J et al.: Systemic lupus erythematosus: clinical and immunological patterns of disease in a cohort of 1000 patients. Medicine (Baltimore) 1993; 72: 113-24.
39. ZECEVIC RD, VOJVODIC D, RISTIC B et al.: Skin lesions - an indicator of disease activity in systemic lupus erythematosus? Lupus 2001; 10: 364-7.
40. TEBBE B, ORFANOS CE: Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6: 96-104.
41. GRIFFITHS B, MOSCA M, GORDON C: Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005; 19: 685-708.
42. HAY EM, BACON PA, GORDON C et al.: The BILAG index - a reliable and valid instrument for measuring clinical-disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-58.
43. PARODI A, MASSONE C, CACCIAPUOTI et al.: Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Derm 2000; 142: 457-60.
44. PETRI M, BARR SG, BUYON J et al.: Responder Index for Lupus Erythematosus [abstract]. Arthritis Rheum 2000; 43: S244.
45. DORIA A, VESCO P, ZULIAN E GAMBARI PF: The 1982 ARA/ACR criteria for the classification of systemic lupus erythematosus in pediatric and adult patients. Clin Exp Rheumatol 1994; 12: 689-90.
46. DORIA A, BIASINUTTO C, GHIRARDELLO A et al.: Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus 1996; 5: 263-8.
47. BOECKLER P, MILEA M, MEYER A: The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency. Br J Dermatol 2005; 152: 265-70.
48. SUAREZ A, LOPEZ P, MOZO L, GUTIERREZ C: Differential effect of IL10 and TNFα genotypes not determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1605-10.
49. TEBBE B, MAZUR L, STADLER R, ORFANOS CE: Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus: relation to immunopathological mechanisms. Br J Dermatol 1995; 132: 25-32.
50. HARRIST TJ, MIHM MC Jr: The specificity and clinical usefulness of the lupus band test. Arthritis Rheum 1980; 23: 479-90.
51. WOUTERS CH, DIEGENANT C, CEUPPENS JL, DEGREEF H, STEVENS EA: The circulating lymphocyte profile in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathegenetic relatioship. Br J Dermatol 2004; 150: 693-700.
52. LEE LA, ROBERTS CHM, FRANK MB et al.: The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 1994; 130: 1262-8.
53. ZAMPIERI S, ALAIBAC M, IACCARINO L et al.: TNF-alpha is expressed in refractory skin lesions from subacute cutaneous lupus erythematosus patients. Ann Rheum Dis 2005 Aug 11; [Epub ahead of print].
54. ARINGER M, SMOLEN JS: Cytokine expression in lupus kidneys. Lupus 2005; 14: 13-8.
55. NURNBERG W, HASS N, SCHADENDORF D et al.: Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol 1995; 4: 52-7.
56. STUART RA, LITTLEWOOD AJ, MADDISON PJ et al.: Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disease. Clin Exp Rheumatol 1995; 13: 17-22.
57. SONTHEIMER RD: Subacute cutaneous lupus erythematosus - A 25 year personal perspective. Autoimmun. Rev 2005; 4: 253-63.
58. WERTH VP, ZHANG W, DORTZBACH K, SULLIVAN K: Association of a promoterr polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct ohotoregulation of transcription. J Invest dermatol 2000; 115: 726-30.
59. RACILA DM, SONTHEIMER CJ, SHEFFIELD A, WISNIESKI JJ, RACILA E, SONTHEIMER RD: Homozygous single nucleotide polymorphism od the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 2003; 12: 124-32.
60. CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
61. KUHN A, HERMANN M, KLEBER S et al.: Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus aftered UV irradiation. Arthritis Rheum 2006; in press.
62. PISONI CN, OBERMOSER G, CUADRADO MJ et al.: Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. Clin Exp Rheumatol 2005; 23: 393-6.